Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.78)
# 726
Out of 5,090 analysts
467
Total ratings
43.31%
Success rate
10.62%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Buy | $70 → $45 | $16.29 | +176.24% | 14 | Dec 2, 2025 | |
| CORT Corcept Therapeutics | Reiterates: Buy | $145 | $84.66 | +71.27% | 25 | Nov 25, 2025 | |
| MDWD MediWound | Maintains: Buy | $31 → $36 | $17.79 | +102.36% | 20 | Nov 21, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $7.45 | +168.64% | 4 | Nov 19, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $4 → $6 | $4.38 | +36.99% | 16 | Nov 18, 2025 | |
| LFWD Lifeward | Maintains: Buy | $13 → $4.5 | $0.76 | +494.69% | 8 | Nov 18, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $130 → $155 | $108.25 | +43.19% | 5 | Nov 17, 2025 | |
| CELC Celcuity | Downgrades: Neutral | $77 → $94 | $105.17 | -10.62% | 11 | Nov 17, 2025 | |
| PGEN Precigen | Maintains: Buy | $8.5 → $9 | $3.81 | +136.22% | 14 | Nov 14, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $55 → $32 | $8.03 | +298.51% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.96 | +30.52% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $43.76 | +7.40% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $3.85 | +29.87% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $81 | $69.47 | +16.60% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $2.5 | $0.32 | +685.89% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.96 | +155.10% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.30 | +249.21% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.98 | +204.58% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $30 | $10.00 | +200.00% | 15 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $5.37 | +197.95% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.04 | +440.28% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.24 | +17.92% | 10 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $3.70 | +305.41% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.28 | +135.29% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.23 | +469.11% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $16.64 | +110.34% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.45 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.95 | +215.09% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.40 | +42.86% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.74 | +101.15% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.29 | +729.69% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.56 | +96.63% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.85 | +9,629.73% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.94 | +406.07% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $36.64 | +63.78% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.18 | +359.61% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.51 | +884.83% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.54 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.00 | +57.14% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $4.42 | +352.36% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.82 | +54.64% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.67 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.81 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.96 | +1,176.94% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.02 | +147.46% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.75 | +3,099.91% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.01 | +1,088.12% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.83 | +2,318.38% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.59 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $9.12 | -34.17% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.82 | +724.18% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $10.37 | +218.23% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $21.52 | -55.86% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.19 | +1,174,199.61% | 1 | Mar 5, 2020 |
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $16.29
Upside: +176.24%
Corcept Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $145
Current: $84.66
Upside: +71.27%
MediWound
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.79
Upside: +102.36%
Actuate Therapeutics
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $7.45
Upside: +168.64%
Ekso Bionics Holdings
Nov 18, 2025
Maintains: Buy
Price Target: $4 → $6
Current: $4.38
Upside: +36.99%
Lifeward
Nov 18, 2025
Maintains: Buy
Price Target: $13 → $4.5
Current: $0.76
Upside: +494.69%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $108.25
Upside: +43.19%
Celcuity
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $105.17
Upside: -10.62%
Precigen
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.81
Upside: +136.22%
Vor Biopharma
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $8.03
Upside: +298.51%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.96
Upside: +30.52%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $43.76
Upside: +7.40%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.85
Upside: +29.87%
Nov 5, 2025
Maintains: Buy
Price Target: $80 → $81
Current: $69.47
Upside: +16.60%
Nov 4, 2025
Assumes: Buy
Price Target: $2.5
Current: $0.32
Upside: +685.89%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.96
Upside: +155.10%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.30
Upside: +249.21%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.98
Upside: +204.58%
Oct 20, 2025
Maintains: Buy
Price Target: $31 → $30
Current: $10.00
Upside: +200.00%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $5.37
Upside: +197.95%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.04
Upside: +440.28%
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $4.24
Upside: +17.92%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $3.70
Upside: +305.41%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.28
Upside: +135.29%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.23
Upside: +469.11%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $16.64
Upside: +110.34%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.45
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.95
Upside: +215.09%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.40
Upside: +42.86%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.74
Upside: +101.15%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.29
Upside: +729.69%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $3.56
Upside: +96.63%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.85
Upside: +9,629.73%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.94
Upside: +406.07%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $36.64
Upside: +63.78%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.18
Upside: +359.61%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.51
Upside: +884.83%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.54
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.00
Upside: +57.14%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $4.42
Upside: +352.36%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.82
Upside: +54.64%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.67
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.81
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.96
Upside: +1,176.94%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.02
Upside: +147.46%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.75
Upside: +3,099.91%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.01
Upside: +1,088.12%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.83
Upside: +2,318.38%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $13.59
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $9.12
Upside: -34.17%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.82
Upside: +724.18%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $10.37
Upside: +218.23%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $21.52
Upside: -55.86%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.19
Upside: +1,174,199.61%